{
  "id": 215472,
  "title": "Greg Verdine’s LifeMine raises $263M for safer immunosuppressant",
  "url": "https://urgent.news/2026/08/06/greg-verdines-lifemine-raises-263m-for-safer-immunosuppressant",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T10:30:08.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/greg-verdines-lifemine-raises-263m-for-safer-immunosuppressant/"
  },
  "original_language": "en",
  "account": null,
  "summary": "LifeMine Therapeutics has hauled in $263 million across two venture rounds as it seeks to test a potentially safer, more convenient immunosuppressant in transplant patients. The infusion includes a previously unannounced $75 million Series D ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}